NEWTBVAC partners
Partners in NEWTBVAC are:
- INTA Institute of Biotechnology (INTA), Argentina
- Institut Scientifique de Santé Publique (WIV), Belgium
- Université Libre de Bruxelles (ULB), Belgium
- GSK-Biologicals (GSK-Bio), Belgium
- Staten Serum Institut (SSI), Denmark
- Centre National de la Recherche Scientifique (CNRS), France
- Institut Pasteur de Lille (IPL), France
- Institut Pasteur (IPAS), France
- PX’Therapeutics (PXT), France
- Eberhard Karls Universität Tübingen (UTUB), Germany
- Universität Ulm (ULM), Germany
- Friedrich-Alexander Universität Erlangen-Nürnberg (ERUH), Germany
- Max-Planck Institute for Infection Biology (MPIIB), Germany
- Istituto Superiore Di Sanità (ISS), Italy
- Università Degli Studi Di Padova (UNIPD), Italy
- Università Degli Studi Di Palermo (UNIPA), Italy
- Educational Foundation Yonsei University (UniYonsei), South Korea
- Institut Pasteur Korea (IPKorea), South Korea
- International Vaccine Institute (IVI), South Korea
- Universidad de Zaragoza (UNIZAR), Spain
- Fundació Institut d’ Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Spain
- Universitätsspital Basel (USB), Switzerland
- Université de Genèva (UNIGE), Switzerland
- Universität Zürich (UZH), Switzerland
- Fondazione Per L’Istituto Di Ricerca in Biomedicina (IRB), Switzerland
- TuBerculosis Vaccine Initiative (TBVI), The Netherlands
- Leiden University Medical Center (LUMC), The Netherlands
- National Institute for Public Heath and the Environment (RIVM),The Netherlands
- Biomedical Primate Research Centre (BPRC), The Netherlands
- Central Veterinary Institute (CVI), The Netherlands
- University of Oxford (UOXF), United Kingdom
- Aston University (ASTON), United Kingdom
- Health Protection Agency Porton Down (HPA-PD), United Kingdom
- National Institute for Biological Standards (NIBSC), United Kingdom
- London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom
- Veterinary Laboratory Agencies (VLA), United Kingdom